Sponsor content

QIAGEN (Suzhou) Translational Medicine Co Profile Jun 2015

BioPharma Dealmakers’ profile of QIAGEN (Suzhou) Translational Medicine Co from June 2015.

Upvote 0
Page of
Go to the profile of QIAGEN (Suzhou) Translational Medicine Co

QIAGEN (Suzhou) Translational Medicine Co

QIAGEN (Suzhou) Translational Medicine Co. (TMC) Ltd. is the first diagnostic R&D company focused on translational science in China. The company provides complete solutions for precision medicine through translational science. Jointly established by QIAGEN and China SIP Biotechnology Development Co. Ltd., QIAGEN (Suzhou) TMC’s mission is the development and validation of biomarkers and companion diagnostics as well as patient stratification for clinical trials.